Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Nutritional and Metabolic Diseases × Urate Oxidase × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Hyperuricemia 3 Lymphoma 2 Leukemia 2 Burkitt Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Nutritional and Metabolic Diseases 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myeloid, Acute 1 Dendritic Cell Sarcoma, Interdigitating 1 Congenital Abnormalities 1 Blast Crisis 1

Interventions

rasburicase 1 Urate Oxidase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00290992 2009-03-30

Rasburicase for Hyperuricemia

Sanofi

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Nutritional and Metabolic Diseases, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡